A robust pH-based second-order spectrophotometric method for the analysis of four anti-HIV drugs in pharmaceutical formulations. [PDF]
Eshlaqi SN +4 more
europepmc +1 more source
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia. [PDF]
Pattanayak SP +17 more
europepmc +1 more source
Virologic Outcomes of Common First-Line Antiretroviral Regimens Among Adults with HIV - China, 2021-2023. [PDF]
Jia H +6 more
europepmc +1 more source
Addressing model overcomplexity in drug-drug interaction prediction with molecular fingerprints. [PDF]
Gil-Sorribes M, Molina A.
europepmc +1 more source
Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat. [PDF]
van Ton AMP +4 more
europepmc +1 more source
Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir [PDF]
openaire +1 more source
Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV. [PDF]
Dyer E +4 more
europepmc +1 more source
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]
Curteis T +17 more
europepmc +1 more source
Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China. [PDF]
Cheng W +6 more
europepmc +1 more source
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Treatment-Naive Patients Living With Human Immunodeficiency Virus (HIV) With High Viral Load: A Retrospective Observational Study. [PDF]
Öztürk Belik H +8 more
europepmc +1 more source

